ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Kabra Drugs Legal & Regulatory

Kabra Drugs received a waiver for ₹0.76 Crore in BSE penalties regarding board composition non-compliance. The exchange accepted the company's waiver application.

Key figures
Value₹0.76 Cr
Source

BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kabra Drugs Ltd: key numbers

Share price
₹18.15
Market cap
₹43.03 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.6×Sector 43.8×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kabra Drugs Ltd

All →

Other legal & regulatory announcements

All →